Centrus Energy reports Thursday with short sellers still holding a heavy position but finding it increasingly expensive and difficult to exit.
Short interest remains at 22.5% of free float — still one of the more crowded short positions in the uranium space. Yet the borrow pool is nearly exhausted. Availability has ticked up from absolute zero (where it spent most of May and early June) to just 4.9%, meaning roughly one share remains available for every 20 already lent out. That marginal loosening has enabled some covering — short interest fell nearly 12% over the past week — but it has driven borrow costs sharply higher in the process. The cost to borrow hit 1.53% on June 15, almost double where it sat for most of May. Bears covering into thin supply are effectively bidding against themselves. The stock itself dropped 6.3% on Tuesday to $165.47, erasing part of last week's 6% rebound, and is down about 9% over the past month. Options positioning is broadly neutral, with the put/call ratio at 0.79 — essentially in line with its 20-day average and well within its annual range.
The analyst debate reflects genuine structural uncertainty. Bulls point to the $900 million DOE award as validation of Centrus's role in domestic uranium enrichment, with B. Riley maintaining a Buy and a $295 target on the thesis that backlog growth and the Piketon expansion represent a multi-year earnings ramp. Bears are less convinced. UBS cut its target to $170 from $195 just yesterday — placing it barely above the current price — while Citigroup held Neutral with a $218 target trimmed from $224 in May. The mean analyst target across the coverage group is $277, implying significant upside from here, but the direction of travel has been one-way: every major firm has lowered targets this year, and only B. Riley holds a positive rating. The key bear risks are execution at Piketon, which carries a $5-7 billion price tag with no firm capital budget disclosed, and continued reliance on Russian TENEX supply that could be disrupted at any point. The ORTEX short score of 72.9 — ranking in the second percentile of the universe — confirms the bearish consensus in positioning data.
The earnings print arrives at a structurally awkward moment for the short base: a meaningful piece of the float is already borrowed, new borrows are scarce, and the last two quarterly results produced an average one-day move of roughly 10% in absolute terms (one up sharply, one down sharply). Institutional ownership tells an interesting story alongside this. State Street added 446,000 shares and Van Eck 313,000 in the most recent reported period, both notable inflows into a stock the shorts are fighting hard to borrow. Insiders, meanwhile, have been net sellers in recent months — the CFO sold in May and the CEO sold in December — though the scale remains small relative to the institutional flows.
Thursday's print is ultimately a test of whether Centrus can provide enough operational clarity on Piketon's timeline and capital requirements to shift the story from speculation to execution — and whether that is enough to move the needle on a short base that is heavy, trapped, and watching the clock.
See the live data behind this article on ORTEX.
Open LEU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
